₨ Official source-observed price
PKR 183.10
1 x 10’s
PKR 18.31 / tablet
✓ Official DRAP price source observed · Source checked 2026-09-23
Price Intelligence
Equivalent price position
Same generic · strength · dosage form · compatible unitPrice Intelligence PRO →
This brandPKR 18.31/ tablet
Price positionNear medianvs like-for-like peer median
Peer comparators13current-price listings
🔒
MedInfoBase Pharma Pro
View Price Intelligence PRO
Unlock the full competitive price benchmark
See the exact peer median, min/max and quartiles, product rank, price percentile and the complete like-for-like competitor table.
Rank & percentilePeer medianFull competitor listPortfolio intelligence
Price-position comparison uses current official listed prices normalized to compatible units. It is a price benchmark, not a measure of sales, demand, prescription volume or market share.
Product details
- Generic
- Olanzapine
- Therapeutic area
- CNS & mental health
- Drug class
- Antipsychotics
- ATC
- N05A
- Strength
- 5 mg
- Dosage form
- Tablet
- Pack
- 1 x 10’s
- Registration no.
- 038671
- Price record verified
- 2026-08-07
- Latest DRAP source check
- 2026-09-23 03:18
Manufacturer
Danas Pharmaceuticals (Pvt) Ltd.
Explore this manufacturer's complete MedInfoBase portfolio, generics and current listed prices.
View company portfolio →Traceability
Official price history
| Amount | Effective from | Verified | Source | Status |
|---|---|---|---|---|
| PKR 183.10 | 2025-11-18 | 2026-08-07 | DRAP PharmaPrice Index | Current |
Same generic
Other listed brands
Amprexa-F 6 mgAmarant Pharmaceuticals Private Limited · PKR 611.33Amprexa-F 12 mgAmarant Pharmaceuticals Private Limited · PKR 1,020.27Amprexa-F 6 mgAmarant Pharmaceuticals Private Limited · PKR 322.18Deprefed-O 12 25 mgFedro Pharmaceutical Labs Pvt Ltd · PKR 343.28Deprefed-O 12 25 mgFedro Pharmaceutical Labs Pvt Ltd · PKR 652.22Deprefed-O 12 25 mgFedro Pharmaceutical Labs Pvt Ltd · PKR 946.65Deprefed-O 6 25 mgFedro Pharmaceutical Labs Pvt Ltd · PKR 287.82Donato 3 mgWinlet Pharmaceuticals (Pvt) Ltd. · PKR 271.50
Evidence note: “Source observed” means MedInfoBase captured the record from an official DRAP source; it does not by itself mean the product registration was independently matched in the DRAP registry. Price note: Unit-price comparisons are informational calculations from official-source pack prices and normalized pack quantities. A pharmacy's transaction price may differ. Verify current regulatory and product information before professional use.
Cite this record
Medicine record · DRAP registration 038671MedInfoBase. (2026). Olepra 5 mg Tablet (1 x 10’s), Danas Pharmaceuticals (Pvt) Ltd. — registration and price record [Data set]. MedInfoBase. Retrieved September 23, 2026, from https://medinfobase.com/brand/olepra-5-mg-038671-1-x-10s-danas-pharmaceuticals-pvt-ltd/ Data observed 7 August 2026. Source: DRAP PharmaPrice Index. DRAP registration 038671.
MedInfoBase. Olepra 5 mg Tablet (1 x 10’s), Danas Pharmaceuticals (Pvt) Ltd. — registration and price record [Internet]. Islamabad: MedInfoBase; 2026 [cited 2026 Sep 23]. Available from: https://medinfobase.com/brand/olepra-5-mg-038671-1-x-10s-danas-pharmaceuticals-pvt-ltd/ Data observed 7 August 2026. Source: DRAP PharmaPrice Index. DRAP registration 038671.
MedInfoBase (2026) Olepra 5 mg Tablet (1 x 10’s), Danas Pharmaceuticals (Pvt) Ltd. — registration and price record. Available at: https://medinfobase.com/brand/olepra-5-mg-038671-1-x-10s-danas-pharmaceuticals-pvt-ltd/ (Accessed: 23 September 2026).
"Olepra 5 mg Tablet (1 x 10’s), Danas Pharmaceuticals (Pvt) Ltd. — registration and price record." MedInfoBase, 2026, https://medinfobase.com/brand/olepra-5-mg-038671-1-x-10s-danas-pharmaceuticals-pvt-ltd/. Accessed 23 Sep 2026.
MedInfoBase. 2026. "Olepra 5 mg Tablet (1 x 10’s), Danas Pharmaceuticals (Pvt) Ltd. — registration and price record." Accessed September 23, 2026. https://medinfobase.com/brand/olepra-5-mg-038671-1-x-10s-danas-pharmaceuticals-pvt-ltd/.
Price and registration data on this page were observed on 7 August 2026. Records change over time, so please cite the observation date alongside the access date.
